The Endocrine Society has issued a guideline on central precocious puberty, which may lead to varying levels of testing and treatment for affected children. The guideline appears to be part of a larger effort by the society to update care for certain conditions, with multiple clinical practice guidelines being released. The specifics of the guideline's recommendations are not clear, but it is intended to inform the care of children with central precocious puberty.